))
The medtech spinout treating Parkinson’s disease with vibrations – Charco Neurotech co-founder Lucy Jung
Manage episode 360332718 series 3321415
Content provided by UKTN. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UKTN or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Lucy Jung, CEO and co-founder of Charco Neurotech, discusses spinning out a medical device startup from academia, the science behind treating Parkinson’s disease with vibrations, balancing regulation with innovation and how devices like Elon Musk’s Neuralink could “maximise our brain”.
Jung, who has a background in design, co-founded Charco Neurotech in 2019, launching out of Imperial College London. It has secured more than $10m in investment for its non-invasive, pebble-shaped device that delivers vibrotactile stimulation to the chest to improve motor performance and alleviate gait freezing for people with Parkinson’s. It can be linked with an accompanying smartphone app to track symptoms and customise treatment. The device is currently used by 900 people, with a further 12,000 on its waiting list.
76 episodes
Share
